Literature DB >> 31112259

Association of Changes in Air Quality With Incident Asthma in Children in California, 1993-2014.

Erika Garcia1, Kiros T Berhane1, Talat Islam1, Rob McConnell1, Robert Urman1, Zhanghua Chen1, Frank D Gilliland1.   

Abstract

Importance: Exposure to air pollutants is a well-established cause of asthma exacerbation in children; whether air pollutants play a role in the development of childhood asthma, however, remains uncertain. Objective: To examine whether decreasing regional air pollutants were associated with reduced incidence of childhood asthma. Design, Setting, and Participants: A multilevel longitudinal cohort drawn from 3 waves of the Southern California Children's Health Study over a period of air pollution decline. Each cohort was followed up from 4th to 12th grade (8 years): 1993-2001, 1996-2004, and 2006-2014. Final follow-up for these data was June 2014. Population-based recruitment was from public elementary schools. A total of 4140 children with no history of asthma and residing in 1 of 9 Children's Health Study communities at baseline were included. Exposures: Annual mean community-level ozone, nitrogen dioxide, and particulate matter less than 10 μm (PM10) and less than 2.5 μm (PM2.5) in the baseline year for each of 3 cohorts. Main Outcomes and Measures: Prospectively identified incident asthma, collected via questionnaires during follow-up.
Results: Among the 4140 children included in this study (mean [SD] age at baseline, 9.5 [0.6] years; 52.6% female [n = 2 179]; 58.6% white [n = 2273]; and 42.2% Hispanic [n = 1686]), 525 incident asthma cases were identified. For nitrogen dioxide, the incidence rate ratio (IRR) for asthma was 0.80 (95% CI, 0.71-0.90) for a median reduction of 4.3 parts per billion, with an absolute incidence rate decrease of 0.83 cases per 100 person-years. For PM2.5, the IRR was 0.81 (95% CI, 0.67-0.98) for a median reduction of 8.1 μg/m3, with an absolute incidence rate decrease of 1.53 cases per 100 person-years. For ozone, the IRR for asthma was 0.85 (95% CI, 0.71-1.02) for a median reduction of 8.9 parts per billion, with an absolute incidence rate decrease of 0.78 cases per 100 person-years. For PM10, the IRR was 0.93 (95% CI, 0.82-1.07) for a median reduction of 4.0 μg/m3, with an absolute incidence rate decrease of 0.46 cases per 100 person-years. Conclusions and Relevance: Among children in Southern California, decreases in ambient nitrogen dioxide and PM2.5 between 1993 and 2014 were significantly associated with lower asthma incidence. There were no statistically significant associations for ozone or PM10.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31112259      PMCID: PMC6537847          DOI: 10.1001/jama.2019.5357

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

1.  Assessing the effectiveness of vehicle emission regulations on improving perinatal health: a population-based accountability study.

Authors:  Mary D Willis; Elaine L Hill; Molly L Kile; Susan Carozza; Perry Hystad
Journal:  Int J Epidemiol       Date:  2021-01-23       Impact factor: 7.196

2.  Effects of policy-driven hypothetical air pollutant interventions on childhood asthma incidence in southern California.

Authors:  Erika Garcia; Robert Urman; Kiros Berhane; Rob McConnell; Frank Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-22       Impact factor: 11.205

3.  Childhood Origins of Adult Lung Disease as Opportunities for Prevention.

Authors:  Torie Grant; Emily P Brigham; Meredith C McCormack
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03

4.  Transcriptional Profiling of the Murine Airway Response to Acute Ozone Exposure.

Authors:  Adelaide Tovar; Gregory J Smith; Joseph M Thomas; Wesley L Crouse; Jack R Harkema; Samir N P Kelada
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

5.  The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.

Authors:  Loretta Erhunmwunsee; Sam E Wing; Jenny Shen; Hengrui Hu; Ernesto Sosa; Lisa N Lopez; Catherine Raquel; Melissa Sur; Pilar Ibarra-Noriega; Madeline Currey; Janet Lee; Jae Y Kim; Dan J Raz; Arya Amini; Sagus Sampath; Marianna Koczywas; Erminia Massarelli; Howard L West; Karen L Reckamp; Rick A Kittles; Ravi Salgia; Victoria L Seewaldt; Susan L Neuhausen; Stacy W Gray
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-04       Impact factor: 4.254

6.  Comparison of childhood asthma incidence in 3 neighbouring cities in southwestern Ontario: a 25-year longitudinal cohort study.

Authors:  Dhenuka Radhakrishnan; Sarah E Bota; April Price; Alexandra Ouédraogo; Murad Husein; Kristin K Clemens; Salimah Z Shariff
Journal:  CMAJ Open       Date:  2021-05-04

7.  Decreasing ten-year (2008-2018) trends of the prevalence of childhood asthma and air pollution in Southern Taiwan.

Authors:  Wei-Yu Chen; Ching-Wei Lin; Ju Lee; Po-Sung Chen; Hui-Ju Tsai; Jiu-Yao Wang
Journal:  World Allergy Organ J       Date:  2021-04-29       Impact factor: 4.084

8.  Contribution of Satellite-Derived Aerosol Optical Depth PM2.5 Bayesian Concentration Surfaces to Respiratory-Cardiovascular Chronic Disease Hospitalizations in Baltimore, Maryland.

Authors:  John T Braggio; Eric S Hall; Stephanie A Weber; Amy K Huff
Journal:  Atmosphere (Basel)       Date:  2020-02-18       Impact factor: 2.686

9.  Prenatal and early life exposure to particulate matter, environmental tobacco smoke and respiratory symptoms in Mexican children.

Authors:  Nadya Y Rivera Rivera; Marcela Tamayo-Ortiz; Adriana Mercado García; Allan C Just; Itai Kloog; Martha Maria Téllez-Rojo; Robert O Wright; Rosalind J Wright; Maria José Rosa
Journal:  Environ Res       Date:  2020-10-22       Impact factor: 6.498

10.  Calling Attention to the Role of Race-Driven Societal Determinants of Health on Aggressive Tumor Biology: A Focus on Black Americans.

Authors:  Kimlin T Ashing; Veronica Jones; Fornati Bedell; Tanyanika Phillips; Loretta Erhunmwunsee
Journal:  JCO Oncol Pract       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.